Results of a new study show that patients with major depressive order who have not been helped by antidepressants could ...

Nitrous oxide may offer quick, short-term relief for people with major depression, especially those who haven’t responded to ...

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, said it amended its Investigational New Drug filing for NRX-101 to include use of the drug in combination with ...

Let’s face it. We need to think outside the box when it comes to managing increasing rates of depression. The current approach relies on the timely identification of symptoms, followed by a ...

A new clinical trial shows that deep brain stimulation (DBS) improved symptoms in half of adults with treatment-resistant depression, with one-third reaching remission.

No one is immune to depression. It can occur in those who are susceptible by virtue of family history or biology; chronic poverty, disease, or deprivation; or childhood experience that resets ...

Moment of Clarity has published a new educational article titled “Spravato for Bipolar Depression Treatment“, providing an in-depth exploration of how esketamine therapy is being used to manage ...

For decades, researchers have developed and tested adolescent depression prevention programs that show strong results. But a new study reveals a major flaw in the evidence base: These programs, ...

A version of this article was originally published on Psychiatric Times. This version has been lightly edited. According to a new study, treating depression could lower the risk of dementia for ...

Major depressive disorder (MDD) is characterized by a lowered mood and loss of interest, contributing not only to ...

Austin, Texas, United States, December 3rd, 2025, FinanceWire NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, said ...